Literature DB >> 21252997

Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.

Chris Jopling1, Stephanie Boue, Juan Carlos Izpisua Belmonte.   

Abstract

The ultimate goal of regenerative medicine is to replace lost or damaged cells. This can potentially be accomplished using the processes of dedifferentiation, transdifferentiation or reprogramming. Recent advances have shown that the addition of a group of genes can not only restore pluripotency in a fully differentiated cell state (reprogramming) but can also induce the cell to proliferate (dedifferentiation) or even switch to another cell type (transdifferentiation). Current research aims to understand how these processes work and to eventually harness them for use in regenerative medicine.

Mesh:

Year:  2011        PMID: 21252997     DOI: 10.1038/nrm3043

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  108 in total

1.  Transcriptomics approach to investigate zebrafish heart regeneration.

Authors:  Eduard Sleep; Stéphanie Boué; Chris Jopling; Marina Raya; Angel Raya; Juan Carlos Izpisua Belmonte
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-05       Impact factor: 2.160

2.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.

Authors:  J G Flanagan; D C Chan; P Leder
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  Physical interaction between TBX5 and MEF2C is required for early heart development.

Authors:  Tushar K Ghosh; Fei Fei Song; Elizabeth A Packham; Sarah Buxton; Thelma E Robinson; Jonathan Ronksley; Tim Self; Andrew J Bonser; J David Brook
Journal:  Mol Cell Biol       Date:  2009-02-09       Impact factor: 4.272

4.  Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.

Authors:  Takao Kuroda; Masako Tada; Hiroshi Kubota; Hironobu Kimura; Shin-ya Hatano; Hirofumi Suemori; Norio Nakatsuji; Takashi Tada
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb.

Authors:  W R MacLellan; A Garcia; H Oh; P Frenkel; M C Jordan; K P Roos; M D Schneider
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation.

Authors:  Chris Jopling; Eduard Sleep; Marina Raya; Mercè Martí; Angel Raya; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

7.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

8.  Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.

Authors:  Zachary D Smith; Iftach Nachman; Aviv Regev; Alexander Meissner
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

9.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  257 in total

Review 1.  Find and replace: editing human genome in pluripotent stem cells.

Authors:  Huize Pan; Weiqi Zhang; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2011-12-15       Impact factor: 14.870

2.  Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.

Authors:  James B Papizan; Ruth A Singer; Shuen-Ing Tschen; Sangeeta Dhawan; Jessica M Friel; Susan B Hipkens; Mark A Magnuson; Anil Bhushan; Lori Sussel
Journal:  Genes Dev       Date:  2011-11-01       Impact factor: 11.361

Review 3.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

4.  Rejuvenating liver and pancreas through cell transdifferentiation.

Authors:  Fei Yi; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-02-28       Impact factor: 25.617

Review 5.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

6.  Peptide amphiphile delivery of sonic hedgehog protein promotes neurite formation in penile projecting neurons.

Authors:  Ryan Dobbs; Shawn Choe; Elizabeth Kalmanek; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek
Journal:  Nanomedicine       Date:  2018-07-04       Impact factor: 5.307

Review 7.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

Review 8.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium.

Authors:  Bo Yu; Pei Xu; Zhenyang Zhao; Jiyang Cai; Paul Sternberg; Yan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.